MedInvest Conferences, a leading events and publishing company in the biotech and medtech investment space, will host its annual MedInvest Neurological Diseases and Mental Health Disorders Conference September 8-9, 2021. The conference is the leading event for companies in the CNS and CNS related spaces, with the inclusion of peripheral nervous system issues, seeking financing.
The conference will feature over 40 presenting companies, 4 keynote talks, panels, and 150+ investors, along with a partnering system to enable investors and presenting companies to have side discussions regarding potential investors.
The conference applies to a broad range of companies, including, but not limited to: Neurology, Neurovascular and Stroke, Cerebral Edema, Epilepsy, Seizures, Coma, Pain, Movement Disorders (e.g. Cerebral Palsy), Degenerative Disorders (Alzheimer’s, Parkinson’s, etc.), Demyelinating Diseases, Psychiatry, Mental Illness, Addiction, Neuro-Genetic Diseases, Sleep Disorders, Headaches, Orthostatic Hypotension, PHN, Post-Polio Myelitis, Restless Legal Syndrome, Diabetic Neuropathy as well as other peripheral diseases.